Researchers Examine Psilocybin Patent Claims
A patent granted to Compass Pathways is drawing attention to how pharmaceutical companies might end up owning forms of long-established psychedelic substances. Part 2 of a 3-part series.
A patent granted to Compass Pathways is drawing attention to how pharmaceutical companies might end up owning forms of long-established psychedelic substances. Part 2 of a 3-part series.